Acyclovir price index

Acyclovir price December 2025 and outlook (see chart below)

• India:US$39.96/KG, -0.6% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Acyclovir price index

This post is a summary of the Acyclovir price developments. The price developments of Acyclovir are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Acyclovir price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Acyclovir prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Acyclovir prices
• Recent price developments of underlying feedstocks which drive the price of Acyclovir
• Market futures for both cost drives and feedstocks of Acyclovir prices
• Adjustment of current supply/demand imbalances in the Acyclovir market
• Longer term trends in likely demand conditions

What is Acyclovir and what is it used for

Acyclovir (also written aciclovir) is a nucleoside analogue antiviral that inhibits viral DNA synthesis and is used to treat infections caused by herpesviruses — chiefly herpes simplex virus (oral and genital herpes), varicella-zoster virus (chickenpox and shingles), and certain severe infections such as HSV encephalitis. It is available in topical, oral and intravenous formulations and is a first-line therapy for many herpes infections.

How is Acyclovir produced

Acyclovir is manufactured by chemical synthesis starting from guanine or guanine derivatives; common routes protect and functionalize the guanine nucleus (for example silylation or acetylation), then introduce the 9-(2-hydroxyethoxymethyl) side chain via condensation or related steps, followed by deprotection and purification. There are many published routes and patented processes that emphasize economical, high-yield steps and scalable conditions for API manufacture.

How large is the global market for Acyclovir

Market estimates vary by source and forecast year; recent market-research reports place the global acyclovir market in the low-to-mid single-digit billions USD range (examples: roughly USD 2.6–3.1 billion reported for 2024/2021 by some firms, while other reports estimate higher values — e.g. USD ~5.2 billion in 2024 — with projected growth through the 2020s). Differences reflect whether reports count only the API, finished formulations, branded vs generics, and differing forecast windows; expect a reasonable current market-size range of about USD 2.5–5.5 billion depending on the methodology.

Where is Acyclovir produced

Acyclovir API and finished products are produced worldwide but manufacturing is concentrated in regions with large generic pharmaceutical industries — notably China and India — alongside manufacturers in Europe, the United States and other countries. Directories of API suppliers and exporters list multiple Chinese and Indian producers as well as suppliers in the US, EU and elsewhere, so supply is geographically diversified but with strong production capacity in Asia.